MCP Waters-The Science of What's Possible
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/mcp.M700545-MCP200 on May 12, 2008.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700545-MCP200v1
7/8/1570    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Lavatelli, F.
Right arrow Articles by Costello, C. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lavatelli, F.
Right arrow Articles by Costello, C. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 7:1570-1583, 2008.
© 2008 by The American Society for Biochemistry and Molecular Biology, Inc.


Research

Amyloidogenic and Associated Proteins in Systemic Amyloidosis Proteome of Adipose Tissue*,S

Francesca Lavatelli{ddagger},§,||, David H. Perlman||,**, Brian Spencer{ddagger}, Tatiana Prokaeva{ddagger}, Mark E. McComb**, Roger Théberge{ddagger},**, Lawreen H. Connors{ddagger},{ddagger}{ddagger}, Vittorio Bellotti§§, David C. Seldin{ddagger}, Giampaolo Merlini§, Martha Skinner{ddagger} and Catherine E. Costello{ddagger},**,{ddagger}{ddagger},¶¶

From the {ddagger} Amyloid Treatment and Research Program, ** Center for Biomedical Mass Spectrometry, and {ddagger}{ddagger} Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118 and § Amyloid Center, Department of Internal Medicine, Foundation Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, and §§ Biochemistry Department, University of Pavia, 27100 Pavia, Italy

In systemic amyloidoses, widespread deposition of protein as amyloid causes severe organ dysfunction. It is necessary to discriminate among the different forms of amyloid to design an appropriate therapeutic strategy. We developed a proteomics methodology utilizing two-dimensional polyacrylamide gel electrophoresis followed by matrix-assisted laser desorption/ionization mass spectrometry and peptide mass fingerprinting to directly characterize amyloid deposits in abdominal subcutaneous fat obtained by fine needle aspiration from patients diagnosed as having amyloidoses typed as immunoglobulin light chain or transthyretin. Striking differences in the two-dimensional gel proteomes of adipose tissue were observed between controls and patients and between the two types of patients with distinct, additional spots present in the patient specimens that could be assigned as the amyloidogenic proteins in full-length and truncated forms. In patients heterozygotic for transthyretin mutations, wild-type peptides and peptides containing amyloidogenic transthyretin variants were isolated in roughly equal amounts from the same protein spots, indicative of incorporation of both species into the deposits. Furthermore novel spots unrelated to the amyloidogenic proteins appeared in patient samples; some of these were identified as isoforms of serum amyloid P and apolipoprotein E, proteins that have been described previously to be associated with amyloid deposits. Finally changes in the normal expression pattern of resident adipose proteins, such as down-regulation of {alpha}B-crystallin, peroxiredoxin 6, and aldo-keto reductase I, were observed in apparent association with the presence of amyloid, although their levels did not strictly correlate with the grade of amyloid deposition. This proteomics approach not only provides a way to detect and unambiguously type the deposits in abdominal subcutaneous fat aspirates from patients with amyloidoses but it may also have the capability to generate new insights into the mechanism of the diseases by identifying novel proteins or protein post-translational modifications associated with amyloid infiltration.


¶¶ To whom correspondence should be addressed: Center for Biomedical Mass Spectrometry, Boston University School of Medicine, 670 Albany St., Rm. 511, Boston, MA 02118-2646. Tel.: 617-638-6490; Fax: 617-638-6491; E-mail: cecmsms{at}bu.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.